Rchr
J-GLOBAL ID:201101031993400113   Update date: Apr. 08, 2024

Yabe Daisuke

Yabe Daisuke
Affiliation and department:
Job title: Professor and Chairman
Homepage URL  (1): https://www.kuhp.kyoto-u.ac.jp/department/departments/den.html
Research field  (5): Physical and health education ,  Metabolism and endocrinology ,  Metabolism and endocrinology ,  Metabolism and endocrinology ,  Pathobiochemistry
Research keywords  (9): Neuroendocrine tumors ,  Obesity ,  Pancreatic beta cells ,  Diabetes education ,  Endocrine disorders ,  Nutrition ,  Dislipidemia ,  Diabetes ,  Incretin
Research theme for competitive and other funds  (40):
  • 2023 - 2027 Establishment of individualized nutrition therapy that contributes to the prevention of geriatric syndrome by regional cohort and deep learning
  • 2022 - 2027 糖尿病根治を目指したMYCLによるリプログラミングを介した膵島再生医療の開発
  • 2023 - 2025 「食べる順番が糖代謝・摂食調節を制御する分子メカニズムの解明」
  • 2023 - 2024 ゲノム改変技術によるMODYマウスの構築
  • 2023 - 2024 ヒトと犬の共通疾患に対する標準化診断コードシステムの構築
Show all
Papers (241):
  • Suzuki R, Amadid H, Major-Pedersen A, Yabe D. PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan. Journal of Diabetes Investigation. 2024. in press
  • Tomoyuki Haba, Kengo Yamakawa, Sayako Ozeki, Akira Sumida, Takehiro Kato, Eiji Kuroda, Takako Maruyama, Takaaki Murakami, Daisuke Yabe. A case of insulinoma misidentified as schizophrenia due to its manifestation in neuropsychiatric symptoms. Diabetology International. 2024. in press
  • 窪田創大, 矢田俊彦, 矢部大介. GLP-1 受容体作動薬:肥満症の標準治療薬となるか?. 肥満研究. 2024. 29. 3. 76-82
  • Nakano E, Mukai K, Fukuhara A, Otsuki M, Shimomura I, Ichijo T, Tsuiki M, Wada N, Yoneda T, Takeda Y, Oki K, Yamada T, Ogawa Y, Yabe D, Kakutani M, Sone M, Katabami T, Tanabe A, Mitsuhide N. Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation. Endocrine Journal. 2024. in press
  • Horikawa Y, HosomichiK, Yabe D. Monogenic Diabetes. Diabetology International. 2024. in press
more...
MISC (373):
  • 水野正巳, 矢部大介. 患者さんからよく尋ねられる内科診療のQuestion Q大福などの甘いものを食べると家族に怒られます。糖尿病があったら、絶対に食べてはだめなんですか?. 臨床雑誌内科. 2024. 133. 4. 965-968
  • 堀谷愛美, 加藤丈博, 矢部大介. インクレチン関連薬(DPP-4阻害薬、GLP-1受容体作動薬). Current Therapy. 2024. 42. 2. 26-31
  • 矢部大介. もう一つのインクレチンGIP. 糖尿病ライフさかえ. 2023. 63. 11. 5-9
  • 矢部大介. One Medicine創薬シーズ開発・育成研究教育拠点(COMIT). 東海国立大学機構統合報告書「INTEGRATED REPORT2023」. 2023. 71-72
  • 矢部大介. 質疑応答 プロからプロへ 持続性GIP/GLP-1受容体作動薬の使い分けと位置づけについて. 日本医事新報. 2023. 5183. 53-54
more...
Books (48):
  • 今日の治療指針 私はこう治療している
    医学書院 2024
  • 血糖だけにこだわらない!糖尿病治療薬の考え方、使い方
    日本医事新報社 2023
  • 改訂第9版 糖尿病専門医研修ガイドブック
    日本糖尿病学会 2023
  • 改訂第9版 糖尿病専門医研修ガイドブック
    日本糖尿病学会 2023
  • 内分泌代謝・糖尿病内科領域専門医研修ガイドブック
    日本内分泌学会・日本糖尿病学会 2023
more...
Lectures and oral presentations  (259):
  • 医療におけるAI活用の現状と課題
    (第27回日本病態栄養学会年次学術集会 2024)
  • インクレチンによる糖尿病治療の新展開
    (第44回日本臨床薬理学会 2023)
  • インクレチンと糖尿病性腎症: GLP-1受容体作動薬、GIP/GLP-1受容体作動薬への期待
    (第34回日本糖尿病性腎症研究会 2023)
  • Anti-diabetes Measures from Asia Perspectives: Focus on Medical Nutrition Therapy and Anti-diabetes Drug Use
    (116th Annual Meeting of Formosan Medical Association 2023)
  • インクレチンによる糖尿病治療の新展開
    (第24回日本内分泌学会近畿支部学術集会 2023)
more...
Professional career (2):
  • MD (Kyoto University)
  • PhD (University of Texas Southwestern Medical Center at Dallas)
Work history (36):
  • 2024/03 - 現在 Kyoto University Hospital Division of Metabolism and Clinical Nutrition Director
  • 2024/03 - 現在 Kyoto University Hospital Department of Diabetes, Endocrinology and Nutrition Director
  • 2024/03 - 現在 Gifu University Center for One Medicine Innovative Translational Research Visiting Professor
  • 2024/03 - 現在 Gifu University Graduate School of Medicine Visiting Professor
  • 2024/03 - 現在 Kyoto University Department of Diabetes, Endocrinology and Nutrition Professor and Chairman
Show all
Committee career (99):
  • 2024/04 - 現在 Japanese Society for Treatment of Obesity Councilor
  • 2023/10 - 現在 Japan Society of Diabetic Complications Auditor
  • 2023/09 - 現在 JST Fusion oriented research for disruptive science and technology Advisor in Tei Panel
  • 2023/04 - 現在 Ministry of Foreign Affairs of Japan, Ministry of Health, Labor and Welfare, Ministry of Education, Culture, Sports, Science and Technology Chair, Nutrition and Metabolism Focus Group, U.S.-Japan Medical Cooperation Program
  • 2023/04 - 現在 Ministry of Health, Labour and Welfare Member of the Planning and Analysis Study Committee for the 2023 National Health and Nutrition Survey
Show all
Awards (9):
  • 2018 - Publons 2018 Peer Review Awards Top 1% in Field (Clinical Medicine)
  • 2017/09 - The Japan Society of Constitutional Medicine Outstanding Research Award
  • 2017/05 - Asian Association for the Study of Diabetes The Masato Kasuga Award for Outstanding Scientific Achivement
  • 2016/01 - Japan Society of Metabolism and Clinical Nutrition Albireo Award
  • 2013/07 - Japan Association for Diabetes Education and Care William Cullen Award
Show all
Association Membership(s) (20):
Japanese Society for Treatment of Obesity ,  Japan Society of Experimental Diabetes and Obesity ,  The Japan Association for Medical Informatics ,  The Japanese Pancreas and Islet Transplantation Association ,  The Japanese Society of Nephrology ,  Japan College of Rheumatology ,  The Japanese Society of Diabetes and Pregnancy ,  The Japanese Society of Ophthalmic Diabetology ,  The Japanese Society of Informatics for Diabetes Mellitus ,  The Japan Society of Diabetic Complications ,  The Japan Society of Constitutional Medicine ,  The Asian Association for the Study of Diabetes ,  American Diabetes Association ,  The European Association for the Study of Diaebtes ,  The Japanese Society of Internal Medicine ,  Japan Society for the Study of Obesity ,  The Japan Endocrine Society ,  Japan Association of Diabetes Education and Care ,  The Japan Society of Metabolism and Clinical Nutrition ,  The Japan Diabetes Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page